Bio/Pharma News

Apr 14, 2014
By Pharmaceutical Technology Editors
EMA sends its results on Roche investigation of pharmacovigilance non-compliance to the European Commission.
Apr 11, 2014
By Pharmaceutical Technology Editors
ThioBridge linker technology to attach different payloads to a range of antibodies
Apr 09, 2014
By Pharmaceutical Technology Editors
Takeda Pharmaceuticals and Eli Lilly announced that they plan to challenge a $9 billion judgment in a lawsuit that alleged Actos caused a patient's bladder cancer.
Apr 07, 2014
By Pharmaceutical Technology Editors
Sun Pharma acquisition of Ranbaxy Laboratories will create the fifth-largest specialty generics company in the world.
Apr 03, 2014
By Pharmaceutical Technology Editors
Evzio, the first naloxone treatment specifically designed to administered to opioid overdose patients by family members or caregivers, approved in 15 weeks.
Mar 27, 2014
By Pharmaceutical Technology Editors
Baxter announces plans to split into two independent companies by mid-2015.
Mar 24, 2014
FDA approves Xolair (omalizumab) for the treatment of a rare skin disease known as chronic idiopathic urticarial.
Mar 05, 2014
By Pharmaceutical Technology Editors
FDA approves the extended-release Bydureon Pen for the treatment of type 2 diabetes.
Feb 26, 2014
FDA approves the orphan drug Myalept for the treatment of leptin deficiency.
Feb 26, 2014
By Pharmaceutical Technology Editors
Moody's Investor Service reports AbbVie, Amgen, and Roche are the most exposed to biosimilar competition.
native1_300x100
lorem ipsum